Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to

Fahd O Ismael1,2, Tessa J Barrett1,2, Diba Sheipouri1

  • 1The Heart Research Institute, Sydney, New South Wales, Australia.

Plos One
|December 21, 2016
PubMed

Insights

Myeloperoxidase oxidants (HOCl, HOSCN) impair lysosomal enzymes in macrophages. Modified LDL also inhibits cathepsins and acid lipase, suggesting a role in atherosclerosis development.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pathology

Background:

  • Low-density lipoprotein (LDL) accumulates lipids in atherosclerotic lesions.
  • Myeloperoxidase (MPO) produces oxidants (HOCl, HOSCN) that modify LDL, contributing to atherosclerosis.
  • Lysosomal enzymes are crucial for cellular lipid and protein processing.

Purpose of the Study:

  • To investigate the impact of HOCl, HOSCN, and oxidized LDL on lysosomal enzyme function in macrophages.
  • To determine how these oxidants and modified LDL affect cathepsin and acid lipase activity.
  • To explore the potential role of lysosomal dysfunction in atherosclerosis pathogenesis.

Main Methods:

  • Murine macrophage-like J774A.1 cells were exposed to HOCl, HOSCN, or LDL pre-treated with these oxidants.
  • Lysosomal cathepsin (B, L, D) and acid lipase activities were quantified.
  • Cathepsin and LAMP-1 protein levels were assessed using Western blotting.

Main Results:

  • HOCl and HOSCN significantly reduced the activity of Cys-dependent cathepsins B and L, but not Asp-dependent cathepsin D.
  • HOSCN-modified LDL and, to a lesser extent, HOCl-modified LDL inhibited cathepsins B and L.
  • Lysosomal acid lipase activity decreased upon exposure to modified LDL.
  • No changes were observed in cathepsin D activity or protein expression levels of cathepsins and LAMP-1.

Conclusions:

  • HOCl, HOSCN, and LDL modified by these oxidants can lead to lysosomal dysfunction in macrophages.
  • This lysosomal dysfunction may impair cellular processing of LDL.
  • These findings suggest a potential mechanism contributing to the development of atherosclerosis.

Related Concept Videos

Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
21.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
857
Inflammation01:38

Inflammation

Overview
63.3K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.0K